The Foundation for Angelman Syndrome Therapeutics (FAST) is the leading patient advocacy organization working to cure Angelman syndrome. As the largest non-governmental funder of Angelman syndrome research in the world, our goal is to drive forward transformative research and development programs as quickly as possible for those living with Angelman syndrome — regardless of age or genotype.
At the core of FAST's mission is a commitment to bring scientific and therapeutic advancements from bench side to bedside, as quickly and safely as possible. To do so, FAST funds projects at every step in the trajectory of drug development, and we are as dedicated to nurturing promising ideas at their earliest stages as we are to protecting and advancing those that have already shown value.
Apply for a grant today. All grant applications are considered on a rolling basis. We move fast so you can too.
Learn More: https://cureangelman.org/apply-for-a-grant
Company Details
- Employees
- 43
- Founded
- -
- Address
- P.o. Box 40607, Austin,tx 78704,united States
- Industry
- Non-Profit Organizations
- Website
- http://www.cureangelman.org/
- Keywords
- Aurora.
- HQ
- Austin, TX
- Competitors
- Foundation for Angelman Syndrome Therapeutics UK (FAST UK), Ultragenyx, Mahzi Therapeutics, FAST Australia - Foundation for Angelman Syndrome Therapeutics, Colin Farrell Foundation, Angelman Syndrome Foundation, AS2 Bio Inc, Biogen, The Michael J. Fox Foundation for Parkinson's Research, Ionis Pharmaceuticals, Inc..
Foundation For Angelman Syndrome Therapeutics Questions
Foundation For Angelman Syndrome Therapeutics's website is http://www.cureangelman.org/
Foundation For Angelman Syndrome Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cureangelman
Foundation For Angelman Syndrome Therapeutics has
43 employees.
View email and phone details for 43
employees at Foundation For Angelman Syndrome Therapeutics.
Foundation For Angelman Syndrome Therapeutics's industry is
Non-profit Organizations
Foundation For Angelman Syndrome Therapeutics's top competitors are
Foundation For Angelman Syndrome Therapeutics Uk (Fast Uk),
Ultragenyx,
Mahzi Therapeutics,
Fast Australia - Foundation For Angelman Syndrome Therapeutics,
Colin Farrell Foundation,
Angelman Syndrome Foundation,
As2 Bio Inc,
Biogen,
The Michael J. Fox Foundation For Parkinson's Research,
Ionis Pharmaceuticals, Inc..
Foundation For Angelman Syndrome Therapeutics's categories are Non-profit Organizations
Foundation For Angelman Syndrome Therapeutics's founding year is 2008
